메뉴 건너뛰기
Drugs in R and D
Volumn 5, Issue 3, 2004, Pages 162-163
Formoterol dry-powder inhalation - Novartis/SkyePharma: Foradil MDDPI, Foradil MDPI, Foradil SkyeHaler, formoterol fumarate dry-powder inhalation
[No Author Info available]
Author keywords

[No Author keywords available]
Indexed keywords

FORMOTEROL FUMARATE;
EID: 2942674294     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200405030-00005     Document Type: Article
Times cited : (2)
References (3)
  • 1
    • 2942640487 scopus 로고    scopus 로고
    • FORADIL® CERTIHALER™ Receives First European Approval
    • SkyePharma PLC. Media Release: 8 Mar Available from URL
    • SkyePharma PLC. FORADIL® CERTIHALER™ Receives First European Approval. Media Release: 8 Mar 2004. Available from URL: http://www.skyepharma.com
    • (2004)
  • 2
    • 2942666465 scopus 로고    scopus 로고
    • FORADIL® CERTIFIALER™ Receives 'Approvable' Letter From FDA
    • SkyePharma PLC. Media Release: 22 Oct Available from URL
    • SkyePharma PLC. FORADIL® CERTIFIALER™ Receives 'Approvable' Letter From FDA. Media Release: 22 Oct 2003. Available from URL: http://www.skyepharma.com
    • (2003)
  • 3
    • 2942685837 scopus 로고    scopus 로고
    • In vitro delivery of formoterol via a novel multi-dose dry powder inhaler, at clinically relevant inspiratory flow rates
    • Sep
    • Singh D, Gilchrist P, Niederlaender C, et al. In vitro delivery of formoterol via a novel multi-dose dry powder inhaler, at clinically relevant inspiratory flow rates. European Respiratory Journal Supplement 22 (Suppl. 45): 472-3, Sep 2003
    • (2003) European Respiratory Journal Supplement , vol.22 , Issue.SUPPL. 45 , pp. 472-473
    • Singh, D.1    Gilchrist, P.2    Niederlaender, C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.